Head-to-head dispatch
SkinnyRx vs Vaylen
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Both molecules by needle or by tablet, with the whole term ladder printed on the product page before any intake — and a headline rate that is the twelve-month rung, charged as one $2,388 payment on day one.
Marked down on: FDA issued Lean Rx, Inc. dba SkinnyRx a warning letter in February 2026; the letter is public in FDA's warning-letter database
FDAWarning letter issued to Lean Rx, Inc. dba SkinnyRx in February 2026. See the FDA warning-letter database.
Desk Score
The strongest all-rounder among the newer entrants — low pricing, brand access, oral routes, and all 50 states on one account.
Marked down on: Newer operator with a shorter track record
Vaylen takes this head-to-head with the higher Desk Score, 91/100 (A−) against 78/100 (C+) for SkinnyRx. SkinnyRx still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
SkinnyRx
78/100
C+
Vaylen
91/100
A−
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | SkinnyRx | Vaylen |
|---|---|---|
| Semaglutide | $349/mo month-to-month (compounded; the advertised rate is a 12-month prepay) | $179/mo |
| Tirzepatide | $399/mo month-to-month (compounded; the advertised rate is a 12-month prepay) | $239/mo |
| Coverage | 47 states + DC (not Alabama, Louisiana or Mississippi) | All 50 states |
| Brand-name | Compounded only | Yes |
| Oral option | Yes | Yes |
| Best for | Readers who want a tablet route on either molecule and can pay a year up front; anyone shopping month to month should compare $349 and $399, not the advertised $199 and $299. | People who want maximum optionality — brand or compounded, oral or injectable — without giving up nationwide reach. |
| Desk Score | 78/100C+ | 91/100A− |
The verdict
Desk pick — VaylenVaylen takes this head-to-head with the higher Desk Score, 91/100 (A−) against 78/100 (C+) for SkinnyRx. SkinnyRx still holds its ground where its strengths line up with yours.
Choose SkinnyRx if…
Readers who want a tablet route on either molecule and can pay a year up front; anyone shopping month to month should compare $349 and $399, not the advertised $199 and $299.
$349/mo month-to-month (compounded; the advertised rate is a 12-month prepay) sema · $399/mo month-to-month (compounded; the advertised rate is a 12-month prepay) tirz · 47 states + DC (not Alabama, Louisiana or Mississippi)
FDAWarning letter issued to Lean Rx, Inc. dba SkinnyRx in February 2026. See the FDA warning-letter database.
Choose Vaylen if…
People who want maximum optionality — brand or compounded, oral or injectable — without giving up nationwide reach.
$179/mo sema · $239/mo tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: SkinnyRx · Vaylen.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- SkinnyRx vs CoreAge Rx
- Vaylen vs Strut Health
- SkinnyRx vs Ondra Health
- Vaylen vs Invigor Medical
- SkinnyRx vs Vytora Health
- Vaylen vs Sesame Care
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.